Can digital adherence technologies reduce inequity in tuberculosis treatment success? Evidence from a randomised controlled trial

INTRODUCTION: Tuberculosis (TB) is a global health emergency and low treatment adherence among patients is a major barrier to ending the TB epidemic. The WHO promotes digital adherence technologies (DATs) as facilitators for improving treatment adherence in resource-limited settings. However, limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutilier, Justin J, Yoeli, Erez, Rathauser, Jon, Owiti, Philip, Subbaraman, Ramnath, Jónasson, Jónas Oddur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716804/
https://www.ncbi.nlm.nih.gov/pubmed/36455988
http://dx.doi.org/10.1136/bmjgh-2022-010512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716804/
https://www.ncbi.nlm.nih.gov/pubmed/36455988
http://dx.doi.org/10.1136/bmjgh-2022-010512

Ejemplares similares